Transmural Systems is a clinical stage medical device company specializing in development of transcatheter therapies for cardiovascular diseases. Having a platform of percutaneous structural heart therapies, the asembled team brings decades of combined implant medical device design, development, quality systems, manufacturing and commercialization experience. The Transmural Systems team has successfully advanced two of its products (Transmural Cerclage and Transcaval Access Closure Device) from early-stage concept to FDA investigational device exemption (IDE) approval, and is currently engaged in early feasibility studies.
